---
title: "Hua Medicine Seeks Shareholder Approval for Digital-Friendly Articles Update"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282968752.md"
description: "Hua Medicine (HK:2552) is seeking shareholder approval to update its constitutional documents, allowing for electronic or hybrid general meetings and electronic voting. This change aims to enhance corporate governance flexibility. The proposed amendments will be presented for approval at the upcoming annual general meeting, with details to be shared in a circular to shareholders. The company, based in the Cayman Islands, emphasizes strong corporate governance with a diverse board structure. Current market cap stands at HK$3.74B with a strong buy sentiment in trading."
datetime: "2026-04-16T08:44:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282968752.md)
  - [en](https://longbridge.com/en/news/282968752.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282968752.md)
---

# Hua Medicine Seeks Shareholder Approval for Digital-Friendly Articles Update

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The latest announcement is out from Hua Medicine ( (HK:2552) ).

Hua Medicine plans to update its constitutional documents by replacing its third amended and restated memorandum and articles of association with a fourth version. The key change is to permit shareholder general meetings to be held as electronic or hybrid meetings and to enable voting by electronic means, alongside related consequential and housekeeping amendments.

The proposed amended articles will require approval by shareholders through a special resolution at the upcoming annual general meeting before taking effect. The company will send a circular detailing the changes and the AGM notice to shareholders in due course, signaling a move toward more flexible and technology-enabled corporate governance arrangements.

**More about Hua Medicine**

Hua Medicine is a biopharmaceutical company incorporated in the Cayman Islands and listed in Hong Kong under stock code 2552. The company is governed by a board comprising executive, non-executive and independent non-executive directors, reflecting a typical listed-company structure focused on corporate governance and shareholder oversight.

**Average Trading Volume:** 3,554,772

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** HK$3.74B

### Related Stocks

- [02552.HK](https://longbridge.com/en/quote/02552.HK.md)

## Related News & Research

- [Hua Medicine Announces 2025 Annual Results](https://longbridge.com/en/news/280735000.md)
- [The Trading Awards: Voting is open until 19 May](https://longbridge.com/en/news/286793607.md)
- [Lytica Launches Supplier Intelligence to Modernize Buyer-Supplier Dynamics in Electronics Procurement](https://longbridge.com/en/news/286921721.md)
- [11:42 ETLG ELECTRONICS NAMED TO 'FORBES 'ACCESSIBILITY 200' LIST](https://longbridge.com/en/news/286940876.md)
- [06:00 ETVon Londoner Bussen bis E-Supermarktflotten: Geotab zeichnet fünf europäische Flotten aus](https://longbridge.com/en/news/286891047.md)